Seres Therapeutics, Inc. Common Stock (NASDAQ: MCRB) last traded at $2.68, down 1.11% on the session. The quote above updates while this page is open; the figures below are drawn from Seres Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Seres Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker MCRB. Its market capitalisation is $26.64 million.
Valuation measures for Seres Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $26.64M |
|---|---|
| Enterprise value | $78.10M |
| Price / sales | 14.15 |
| Price / book | 0.77 |
| Beta | 1.30 |
Trailing-twelve-month figures tagged in Seres Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $1.88M |
|---|---|
| Net income (TTM) | -$22.46M |
| EPS (TTM) | -$2.45 |
| Operating margin | -4462.77% |
| Return on equity | -65.05% |
| Cash | $15.59M |
Range and volume for MCRB over the past 52 weeks.
| 52-week high | $29.98 |
|---|---|
| 52-week low | $2.42 |
| Volume | 54.3K |
| Average volume | 72.0K |
| Previous close | $2.71 |
Invest a chosen dollar amount in Seres Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell MCRB.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.